(To view full size image, click the image or click here.)
A study conducted in 2009 and published in Diabetes, a medical journal, found that the popular type 2 diabetes medication, Januvia, could potentially be linked to pancreatic cancer in patients. Results from the study indicated that Januvia and other incretin mimetics were responsible for the inflammation of the pancreas, a condition known as acute pancreatitis. Should pancreatitis go undetected or untreated, it might develop into pancreatic cancer, one of the most severe diseases of which the prognosis for patients is not good.
Approved by the U.S. Food and Drug Administration (FDA) in 2006, Januvia stimulates the pancreas to increase insulin production and assist the body in correctly and efficiently using the insulin to lower blood sugar levels. Still, several studies have suggested that Januvia and other incretin mimetics may prevent the body from naturally fighting off cancer. If you feel you have a claim and wish to recover damages for your injuries, contact an Arkansas Januvia lawyer today.
If you have suffered from life-threatening complications, contact an Arkansas Januvia lawyer to learn more about your legal rights. According to several clinical trials and adverse event reports submitted to the FDA, Januvia may cause several serious side effects, including:
- Thyroid cancer
- Pancreatic cancer
- Liver cancer
- Kidney damage
Additionally, those taking Januvia have allegedly experienced less severe side effects which may not necessarily indicate a severe problem, including nausea, swelling, fever and pain in the stomach. Those who have received a medical diagnosis from their healthcare providers or who suffered from life-threatening complications are urged to seek legal counsel from an Arkansas Januvia lawyer to learn more about their legal rights.
Statistics show that 14,684 adverse event reports were submitted to the FDA by 2012 from patients who were allegedly suffering from complications while taking Januvia. Of these:
- 1,942 patients were hospitalized
- 765 patients had elevated blood sugar levels
- 625 patients had acute pancreatitis
As the FDA continued to receive reports of complications in Januvia users, the Institute for Safe Medication Practices conducted a study and found that those taking Januvia were at a 25-fold risk of suffering from pancreatic cancer than those who did not take the drug. With results of the study in-hand, the FDA reportedly decided to launch its own investigation to determine the effectiveness and safeness of incretin mimetics as a group.
Need More Information? Contact an Arkansas Januvia Lawyer Today
Attorney Group for Arkansas can provide you with a free, no-obligation consultation if you experienced adverse side effects or were diagnosed with a life-threatening health condition such as pancreatic cancer while taking Januvia. If you have questions about any legal actions to which you may be entitled to take, contact us today and we will address your concerns to the best of our ability. We will also connect you with an affiliated Arkansas Januvia lawyer who will handle your claim should we feel that you are eligible to recover damages for your injuries.